Algernon Pharmaceuticals Inc (AGNPF)

[Money $hot]

Common Sense 101

Facts are not a hard thing to come by if one is seriously interested in finding facts versus filtered fiction. The fact of the matter is you never go to clinicaltrials.gov to follow the latest information coming directly out of the CEO's mouth. You go to the corporate website.

News Release:

...The Company is projecting a data readout in calendar Q2, 2022.

“We are very pleased to announce this update to the market on our IPF and chronic cough study and we look forward to having it completed and presenting the data,” said Christopher J. Moreau, CEO of Algernon Pharmaceuticals.

https://www.globenewswire.com/news-release/2022/02/04/2379200/0/en/Algernon-Pharmaceuticals-Announces-Completion-of-Enrollment-in-its-Phase-2-Study-of-Ifenprodil-for-IPF-and-Chronic-Cough.html

As I stated, management missed yet another quarter just like the pipeline illustration as well.

See IPF/CC "Data - Q2 2022"



Expect Final Data no earlier than Q4 2022.

Just in time for your Annual (Anal) lump of coal stocking stuffer.

CJM IS The Grinch Who Steals Christmas



Just facts,

M$

Postscript

For arguments sake, I read 55's post at Yahoo. He illustrated an "update" regarding the IPF/CC clinical trial. The update is dated March 2022. Now look at the date of the above news release. What would have materially changed from February to March that would suggest Moreau didn't know when data would be available to the public for another quarter (Q2 now Q3)? The bottom line is management missed another quarter to report data from a clinical study that's been fundamentally flawed from the outset.

4D Outro

Think Outside The Box



@ algernonpharma.com